• A case of bullous pemphigoid developing after ixekizumab therapy for pityriasis rubra pilaris
• A case of follicular psoriasis mimicking pityriasis rubra pilaris: a diagnostic dilemma
• A case of paraneoplastic pityriasis rubra pilaris
• A case of pityriasis rubra pilaris treated with tofacitinib after failure with acitretin and ixekizumab
• A case report of refractory advanced-stage mycosis fungoides: successful treatment and improved patient quality of life with mogamulizumab
• A child with CARD14-associated papulosquamous eruption (CAPE) successfully treated with ustekinumab
• A novel mutation in a CARD14-associated papulosquamous eruption
• A Rare Post-infectious Rash: Pityriasis Rubra Pilaris After COVID-19 Infection
• Acute Exfoliative Dermatitis/Erythroderma Secondary to Gliclazide
• An Institution Based Cross-Sectional Observational Aetiological Study Correlating the Clinico-Pathological Findings in Patients Presenting with Acquired Palmoplantar Keratoderma
• Autoinflammatory Keratinization Diseases-The Concept, Pathophysiology, and Clinical Implications
• Bimekizumab bei refraktärer Pityriasis rubra pilaris: Bimekizumab in refractory pityriasis rubra pilaris
• Bimekizumab in refractory pityriasis rubra pilaris
• Biologic treatment options for pityriasis rubra pilaris: An evidence-based systematic review
• Biologics for inherited disorders of keratinisation: A systematic review
• Biologics for Treatment of Pityriasis Rubra Pilaris: A Literature Review
• Case report: Area of focus of management of severe pityriasis rubra pilaris by dose optimization of adalimumab biosimilar in combination with acitretin and montelukast
• Case report: Successful treatment with biologics in a pediatric patient with a severe inflammatory skin disease and novel <em>CARD14</em> mutation
• Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination
• Comment on 'Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine'
• Comment on: 'Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination' by Gambichler
• Corrigendum to "Successful treatment of a child's pityriasis rubra pilaris (PRP)with ustekinumab and acitretin"(1)
• Corrigendum to "Successful treatment of a child's pityriasis rubra pilaris (PRP)with ustekinumab and acitretin"¹
• Cutaneous and Developmental Effects of <em>CARD14</em> Overexpression in Zebrafish
• Delayed Presentation of Pityriasis Rubra Pilaris in a Patient on Treatment With Ponatinib
• Diseases categorized as autoinflammatory keratinization diseases (AiKDs), and their pathologies and treatments
• Early Gestational Diabetes Mellitus: An Update
• Efficacy and safety of oral abrocitinib monotherapy in pityriasis rubra pilaris
• Eosinophils in Traditionally Noneosinophil-Rich Dermatoses
• Erythrodermic Pityriasis Rubra Pilaris Following COVID-19 Vaccination
• Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab
• Guselkumab - In Psoriasis and Beyond
• Guselkumab for Pityriasis Rubra Pilaris and Dysregulation of IL-23/IL-17 and NFkB Signaling: A Nonrandomized Trial
• HIV: Inflammatory dermatoses
• Hyperactivation of the IL-17 axis and IL-36 signaling in Card14-mutant pityriasis rubra pilaris model mice
• Inappropriate Use of Steroids in Superficial Dermatophytosis: An Uncommon Case of Erythroderma
• JAAD Game Changers: "CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris"
• Juvenile Pityriasis Rubra Pilaris
• Juvenile Pityriasis Rubra Pilaris in a 4-year-old Child Treated Successfully with Secukinumab
• Kaposi Varicelliform Eruption
• Kaposi Varicelliform Eruption
• Kaposi's Varicelliform Eruption After Treatment With Ixekizumab in a Patient With Pityriasis Rubra Pilaris
• Key Factors in the Complex and Coordinated Network of Skin Keratinization: Their Significance and Involvement in Common Skin Conditions
• Lichenification
• Lichenification
• Loss-of-function mutations in Keratin 32 gene disrupt skin immune homeostasis in pityriasis rubra pilaris
• Methotrexate and acitretin in pityriasis rubra pilaris: A retrospective cohort study
• Misdiagnosed Pityriasis Rubra Pilaris Successfully Managed With Isotretinoin: A Case Series
• Nail Whispers Revealing Dermatological and Systemic Secrets: An Analysis of Nail Disorders Associated With Diverse Dermatological and Systemic Conditions
• Ophthalmic complication of pityriasis rubra pilaris
• Patient-reported cutaneous signs and symptoms of adult pityriasis rubra pilaris and correlation with quality of life and clinician-reported severity: A cross-sectional study
• Patients with keratinization disorders due to ABCA12 variants showing pityriasis rubra pilaris phenotypes
• Physiotherapy Management of an Adolescent With Pityriasis Rubra Pilaris Along With Rickets
• Pityriasis following COVID-19 vaccinations: a systematic review
• Pityriasis Rubra Pilaris
• Pityriasis Rubra Pilaris
• Pityriasis Rubra Pilaris - a difficult path to optimal treatment. Case report
• Pityriasis rubra pilaris after COVID-19 vaccination: successful treatment with ustekinumab
• Pityriasis Rubra Pilaris After Moderna COVID-19 Vaccination: A Case Report and Literature Review
• Pityriasis rubra pilaris following COVID-19 vaccination successfully treated with ixekizumab
• Pityriasis rubra pilaris following inactivated SARS-CoV-2 vaccine (CoronaVac)
• Pityriasis rubra pilaris induced by topical use of imiquimod 5
• Pityriasis rubra pilaris partially responsive to treatment with upadacitinib: A case report
• Pityriasis Rubra Pilaris Significantly Improved after Treatment for Chronic Focal Infection
• Pityriasis rubra pilaris type IV-associated arthritis treated with adalimumab
• Pityriasis rubra pilaris with rickets: a rare clinical image
• Pityriasis rubra pilaris with simultaneous emergence of human herpesvirus-6 reactivation in a patient with drug-induced hypersensitivity syndrome
• Pityriasis rubra pilaris: a multicenter case series of 65 Spanish patients
• Pityriasis Rubra Pilaris: A Multicentric Case Series of 65 Spanish Patients
• Pityriasis Rubra Pilaris: A Multicentric Case Series of 65 Spanish Patients
• Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options
• Ponatinib Induced Pityriasis Rubra Pilaris: Case Report and Review of Literature
• Ponatinib-Associated Cutaneous Eruptions-A Case Series and Review of Clinicopathologic Findings
• Post-infectious pityriasis rubra pilaris in pediatric patients
• Rapid clearance of extensive juvenile pityriasis rubra pilaris with ixekizumab
• Rapid improvement of severe pityriasis rubra pilaris upon treatment with bimekizumab
• Rapid response of erythrodermic pityriasis rubra pilaris to tildrakizumab
• Refractory pityriasis rubra pilaris treated with upadacitinib
• Resolution of Pityriasis rubra pilaris induced ectropion with oral dexamethasone. A case report
• Rethinking pityriasis rubra pilaris as a paraneoplastic syndrome: Two cases of pityriasis rubra pilaris with concomitant underlying malignancy
• Risankizumab for the treatment of pityriasis rubra pilaris postanaplastic large cell lymphoma
• Role of IL-23 inhibitors including risankizumab and guselkumab in the treatment of pityriasis rubra pilaris
• Severe atypical juvenile pityriasis rubra pilaris diagnosed in adulthood with a dramatic improvement with ustekinumab
• Severe pityriasis rubra pilaris complicated with Kaposi's varicelliform eruption and cutaneous MRSA infection case report
• Sezary syndrome initially presenting as pityriasis rubra pilaris: Clinicopathologic study of 3 cases
• Successful treatment of CARD14-negative juvenile Pityriasis rubra pilaris with Ustekinumab
• Successful treatment of erythrodermic pityriasis rubra pilaris with upadacitinib
• Successful Treatment of Generalized Pustular Psoriasis Coexisting with Pityriasis Rubra Pilaris with Upadacitinib
• Successful treatment of pityriasis rubra pilaris with brodalumab after nonresponse to IL-17A inhibition: A role for the innate cytokine IL-17C
• Successful Treatment of Pityriasis Rubra Pilaris with Risankizumab in Children
• Surgical Management of Severe Cicatricial Ectropion Secondary to Pityriasis Rubra Pilaris
• Targeting IL-1 controls refractory pityriasis rubra pilaris
• The Effectiveness of Anti-Interleukin-17A Treatment for Pityriasis Rubra Pilaris: A Systematic Review
• The individual Pityriasis Rubra Pilaris area and severity index (iPRPASI): validity, reliability, and responsiveness of a novel patient-reported severity tool
• Tildrakizumab use for recalcitrant pityriasis rubra pilaris
• Treatment Options for Juvenile Pityriasis Rubra Pilaris
• Two Incidental Sibling Diagnoses of Netherton Syndrome in Separate Visits: A Case Report
• Updates on Pityriasis Rubra Pilaris: A Scoping Review
• Utility of Dermoscopy in the Diagnosis of Erythroderma: A Cross-Sectional Study
• Wong-type dermatomyositis with interstitial lung disease and anti-SRP and -PM/Scl antibodies treated with intravenous immunoglobulin